PTCT FY 2022 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$6B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$699M+29.7% YoY

Gross Profit

$654M93.6% margin

Operating Income

-$447M-64.0% margin

Net Income

-$559M-80.0% margin

EPS (Diluted)

$-7.79

Cash Flow

Operating Cash Flow

-$357M

Free Cash Flow

-$509M

Stock-Based Comp.

$110M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$2.1B

Stockholders' Equity

-$347M

Cash & Equivalents

$280M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$699M	$539M	+29.7%
Gross Profit	$654M	$506M	+29.2%
Operating Income	-$447M	-$374M	-19.5%
Net Income	-$559M	-$524M	-6.7%